Skip to content

CROI: Fish oil and fibrate combination reduces blood fats in HIV patients

CROI: Merck integrase inhibitor strong in highly treatment-experienced patients

CROI: Side-effects, especially neuropathy and rash, common but rarely severe in two studies of African patients on antiretroviral therapy

CROI: New Gilead integrase inhibitor GS-9137 displays potent activity

CROI: Heart attack risk elevated by protease inhibitor treatment but not NNRTIs

CROI: Tenofovir and kidney toxicity - low rates seen, but some groups may be more vulnerable

CROI: CD4-guided treatment interruptions unsafe, SMART study concludes

CROI: Antiretroviral therapy reduces the high incidence of TB in South African children with HIV

CROI: Abacavir may be safer than nevirapine in Africans, DART sub-study suggests